Current approaches to diagnosing and treating nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is associated with major cardiovascular risk factors, such as type 2 diabetes mellitus, obesity, dyslipidemia, hypertension, and insulin resistance, and has been recently considered to be a new component of metabolic syndrome and it serves as a criterion for...
Main Authors: | O M Drapkina, T A Deeva, N P Volkova, V T Ivashkin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2014-10-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/view/31630 |
Similar Items
-
Low Skeletal Muscle Mass Is a Risk Factor for Subclinical Atherosclerosis in Patients with Nonalcoholic Fatty Liver Disease
by: Min-Kyu Kang, et al.
Published: (2021-05-01) -
Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective
by: Gwyneth Soon, et al.
Published: (2021-01-01) -
Comparison of liver enzymes level and sonographic findings value with liver biopsy findings in nonalcoholic fatty liver disease patients
by: Mahsa Khodadoostan, et al.
Published: (2016-01-01) -
Liver biopsy in the quantitative assessment of liver fibrosis in nonalcoholic fatty liver disease
by: Gwyneth Shook Ting Soon, et al.
Published: (2021-01-01) -
Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease
by: Chan, W.-K, et al.
Published: (2022)